This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Oct 4;7(11):605.

doi: 10.1038/nrneph.2011.128.

Acute kidney injury: Acetylcysteine does not prevent contrast-induced acute kidney injury

PMID: 21971192
DOI: 10.1038/nrneph.2011.128

Comment

Acute kidney injury: Acetylcysteine does not prevent contrast-induced acute kidney injury

Helene Myrvang. Nat Rev Nephrol. 2011.

. 2011 Oct 4;7(11):605.

doi: 10.1038/nrneph.2011.128.

Author

PMID: 21971192
DOI: 10.1038/nrneph.2011.128

No abstract available

PubMed Disclaimer

Comment on

Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
ACT Investigators. ACT Investigators. Circulation. 2011 Sep 13;124(11):1250-9. doi: 10.1161/CIRCULATIONAHA.111.038943. Epub 2011 Aug 22. Circulation. 2011. PMID: 21859972 Clinical Trial.

References

1. Circulation. 2011 Sep 13;124(11):1250-9 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.